Kristen Williams
First SEC filing: June 5, 2026 · Latest: June 5, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 4, 2026 | PCRX | S 10b5-1 | 10,259 | $22.27 | $228,468 | 167,062 Direct | -5.79% | Disposed | 11.9% (price as of 2026-10-06) |
| June 3, 2026 | PCRX | F | 8,528 | $22.32 | $190,345 | 177,321 Direct | -4.59% | Disposed | 11.7% (price as of 2026-10-06) |
| Feb. 11, 2026 | PCRX | A | 54,546 | · | · | 185,849 Direct | +41.54% | Acquired | (price as of 2026-10-06) |
| Feb. 2, 2026 | PCRX | S 10b5-1 | 13,137 | $20.53 | $269,703 | 131,303 Direct | -9.10% | Disposed | 21.4% (price as of 2026-10-06) |
| Jan. 30, 2026 | PCRX | F | 17,134 | $20.54 | $351,932 | 144,440 Direct | -10.60% | Disposed | 21.4% (price as of 2026-10-06) |
| June 4, 2025 | PCRX | S | 14,376 | $26.24 | $377,226 | 161,574 Direct | -8.17% | Disposed | -5.0% (price as of 2026-10-06) |
| June 3, 2025 | PCRX | F | 6,162 | $26.40 | $162,677 | 175,950 Direct | -3.38% | Disposed | -5.6% (price as of 2026-10-06) |
| Feb. 1, 2025 | PCRX | A | 79,200 | · | · | 182,112 Direct | +76.96% | Acquired | (price as of 2026-10-06) |
| June 13, 2024 | PCRX | S 10b5-1 | 7,452 | $28.38 | $211,488 | 102,912 Direct | -6.75% | Disposed | -12.2% (price as of 2026-10-06) |
| June 12, 2024 | PCRX | A | 54,300 | · | · | 110,364 Direct | +96.85% | Acquired | (price as of 2026-10-06) |
| June 3, 2024 | PCRX | F | 3,011 | $30.89 | $93,010 | 56,064 Direct | -5.10% | Disposed | -19.3% (price as of 2026-10-06) |
| Feb. 5, 2024 | PCRX | A | 33,700 | · | · | 59,075 Direct | +132.81% | Acquired | (price as of 2026-10-06) |
| June 14, 2023 | PCRX | A | 27,500 | · | · | 27,500 Direct | · | Acquired | (price as of 2026-10-06) |
| June 14, 2023 | PCRX | S 10b5-1 | 6,467 | $37.03 | $239,473 | 25,375 Direct | -20.31% | Disposed | -32.7% (price as of 2026-10-06) |
| June 14, 2023 | PCRX | A | 10,950 | · | · | 31,842 Direct | +52.41% | Acquired | (price as of 2026-10-06) |
| June 7, 2023 | PCRX | S | 1,357 | $37.86 | $51,376 | 20,892 Direct | -6.10% | Disposed | -34.2% (price as of 2026-10-06) |
| June 6, 2023 | PCRX | S | 1,301 | $38.99 | $50,726 | 22,249 Direct | -5.52% | Disposed | -36.1% (price as of 2026-10-06) |
| June 8, 2022 | PCRX | A | 24,800 | · | · | 24,800 Direct | · | Acquired | (price as of 2026-10-06) |
| June 8, 2022 | PCRX | A | 9,900 | · | · | 23,550 Direct | +72.53% | Acquired | (price as of 2026-10-06) |
| June 7, 2022 | PCRX | S 10b5-1 | 4,649 | $59.51 | $276,662 | 13,650 Direct | -25.41% | Disposed | -58.1% (price as of 2026-10-06) |
| June 6, 2022 | PCRX | S 10b5-1 | 3,969 | $61.37 | $243,578 | 18,299 Direct | -17.82% | Disposed | -59.4% (price as of 2026-10-06) |
| March 21, 2022 | PCRX | M | 2,188 | · | · | 19,685 Direct | -10.00% | Disposed | (price as of 2026-10-06) |
| March 21, 2022 | PCRX | M | 2,112 | · | · | 10,560 Direct | -16.67% | Disposed | (price as of 2026-10-06) |
| March 21, 2022 | PCRX | M | 2,953 | · | · | 2,953 Direct | -50.00% | Disposed | (price as of 2026-10-06) |
| March 21, 2022 | PCRX | S 10b5-1 | 7,253 | $72.67 | $527,076 | 22,268 Direct | -24.57% | Disposed | -65.7% (price as of 2026-10-06) |
| March 21, 2022 | PCRX | M 10b5-1 | 2,188 | $47.65 | $104,258 | 29,521 Direct | +8.00% | Acquired | -47.7% (price as of 2026-10-06) |
| March 21, 2022 | PCRX | M 10b5-1 | 2,112 | $43.54 | $91,956 | 27,333 Direct | +8.37% | Acquired | -42.7% (price as of 2026-10-06) |
| March 21, 2022 | PCRX | M 10b5-1 | 2,953 | $38.35 | $113,248 | 25,221 Direct | +13.26% | Acquired | -35.0% (price as of 2026-10-06) |
| Feb. 25, 2022 | PCRX | M 10b5-1 | 2,050 | $38.35 | $78,618 | 24,318 Direct | +9.21% | Acquired | -35.0% (price as of 2026-10-06) |
| Feb. 25, 2022 | PCRX | S 10b5-1 | 50 | $65.00 | $3,250 | 24,268 Direct | -0.21% | Disposed | -61.6% (price as of 2026-10-06) |
| Feb. 25, 2022 | PCRX | S 10b5-1 | 2,000 | $67.07 | $134,140 | 22,268 Direct | -8.24% | Disposed | -62.8% (price as of 2026-10-06) |
| Feb. 25, 2022 | PCRX | M | 2,050 | · | · | 5,906 Direct | -25.77% | Disposed | (price as of 2026-10-06) |
| Feb. 16, 2022 | PCRX | M 10b5-1 | 10 | $38.35 | $384 | 22,278 Direct | +0.04% | Acquired | -35.0% (price as of 2026-10-06) |
| Feb. 16, 2022 | PCRX | S 10b5-1 | 10 | $65.00 | $650 | 22,268 Direct | -0.04% | Disposed | -61.6% (price as of 2026-10-06) |
| Feb. 16, 2022 | PCRX | M | 10 | · | · | 7,956 Direct | -0.13% | Disposed | (price as of 2026-10-06) |
| Feb. 10, 2022 | PCRX | M | 800 | · | · | 7,966 Direct | -9.13% | Disposed | (price as of 2026-10-06) |
| Feb. 10, 2022 | PCRX | S 10b5-1 | 800 | $65.18 | $52,144 | 22,268 Direct | -3.47% | Disposed | -61.8% (price as of 2026-10-06) |
| Feb. 10, 2022 | PCRX | M 10b5-1 | 800 | $38.35 | $30,680 | 23,068 Direct | +3.59% | Acquired | -35.0% (price as of 2026-10-06) |
| Feb. 4, 2022 | PCRX | M | 1,000 | · | · | 8,766 Direct | -10.24% | Disposed | (price as of 2026-10-06) |
| Feb. 4, 2022 | PCRX | S 10b5-1 | 1,000 | $65.18 | $65,180 | 22,268 Direct | -4.30% | Disposed | -61.8% (price as of 2026-10-06) |
| Feb. 4, 2022 | PCRX | M 10b5-1 | 1,000 | $38.35 | $38,350 | 23,268 Direct | +4.49% | Acquired | -35.0% (price as of 2026-10-06) |
| Jan. 21, 2022 | PCRX | M | 200 | · | · | 9,766 Direct | -2.01% | Disposed | (price as of 2026-10-06) |
| Jan. 21, 2022 | PCRX | S 10b5-1 | 200 | $65.41 | $13,082 | 22,268 Direct | -0.89% | Disposed | -61.9% (price as of 2026-10-06) |
| Jan. 21, 2022 | PCRX | M 10b5-1 | 200 | $38.35 | $7,670 | 22,468 Direct | +0.90% | Acquired | -35.0% (price as of 2026-10-06) |
| Jan. 19, 2022 | PCRX | M | 2,199 | · | · | 9,966 Direct | -18.08% | Disposed | (price as of 2026-10-06) |
| Jan. 19, 2022 | PCRX | S 10b5-1 | 2,199 | $65.51 | $144,056 | 22,268 Direct | -8.99% | Disposed | -61.9% (price as of 2026-10-06) |
| Jan. 19, 2022 | PCRX | M 10b5-1 | 2,199 | $38.35 | $84,332 | 24,467 Direct | +9.88% | Acquired | -35.0% (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | M | 13,127 | · | · | 21,873 Direct | -37.51% | Disposed | (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | M | 6,338 | · | · | 12,672 Direct | -33.34% | Disposed | (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | M | 2,600 | · | · | 12,165 Direct | -17.61% | Disposed | (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | M | 1,375 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | S 10b5-1 | 400 | $66.14 | $26,456 | 22,268 Direct | -1.76% | Disposed | -62.3% (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | S 10b5-1 | 23,040 | $65.24 | $1,503,130 | 22,668 Direct | -50.41% | Disposed | -61.8% (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | M 10b5-1 | 13,127 | $47.65 | $625,502 | 45,708 Direct | +40.29% | Acquired | -47.7% (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | M 10b5-1 | 6,338 | $43.54 | $275,957 | 32,581 Direct | +24.15% | Acquired | -42.7% (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | M 10b5-1 | 2,600 | $38.35 | $99,710 | 26,243 Direct | +11.00% | Acquired | -35.0% (price as of 2026-10-06) |
| Jan. 18, 2022 | PCRX | M 10b5-1 | 1,375 | $44.20 | $60,775 | 23,643 Direct | +6.17% | Acquired | -43.6% (price as of 2026-10-06) |
| June 10, 2021 | PCRX | S 10b5-1 | 4,842 | $59.43 | $287,760 | 23,115 Direct | -17.32% | Disposed | -58.1% (price as of 2026-10-06) |
| June 10, 2021 | PCRX | S 10b5-1 | 847 | $60.57 | $51,303 | 22,268 Direct | -3.66% | Disposed | -58.8% (price as of 2026-10-06) |
| June 9, 2021 | PCRX | A | 7,000 | · | · | 27,957 Direct | +33.40% | Acquired | (price as of 2026-10-06) |
| June 9, 2021 | PCRX | A | 17,500 | · | · | 17,500 Direct | · | Acquired | (price as of 2026-10-06) |
| June 4, 2021 | PCRX | S | 3,930 | $61.04 | $239,887 | 20,957 Direct | -15.79% | Disposed | -59.2% (price as of 2026-10-06) |
| April 13, 2021 | PCRX | M | 6,339 | · | · | 19,010 Direct | -25.01% | Disposed | (price as of 2026-10-06) |
| April 13, 2021 | PCRX | M | 8,859 | · | · | 14,765 Direct | -37.50% | Disposed | (price as of 2026-10-06) |
| April 13, 2021 | PCRX | M | 4,125 | · | · | 1,375 Direct | -75.00% | Disposed | (price as of 2026-10-06) |
| April 13, 2021 | PCRX | M | 2,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| April 13, 2021 | PCRX | S 10b5-1 | 7,030 | $68.11 | $478,813 | 24,887 Direct | -22.03% | Disposed | -63.4% (price as of 2026-10-06) |
| April 13, 2021 | PCRX | S 10b5-1 | 14,793 | $66.40 | $982,255 | 31,917 Direct | -31.67% | Disposed | -62.5% (price as of 2026-10-06) |
| April 13, 2021 | PCRX | M 10b5-1 | 6,339 | $43.54 | $276,000 | 46,710 Direct | +15.70% | Acquired | -42.7% (price as of 2026-10-06) |
| April 13, 2021 | PCRX | M 10b5-1 | 8,859 | $38.35 | $339,743 | 40,371 Direct | +28.11% | Acquired | -35.0% (price as of 2026-10-06) |
| April 13, 2021 | PCRX | M 10b5-1 | 4,125 | $44.20 | $182,325 | 31,512 Direct | +15.06% | Acquired | -43.6% (price as of 2026-10-06) |
| April 13, 2021 | PCRX | M 10b5-1 | 2,500 | $32.35 | $80,875 | 27,387 Direct | +10.05% | Acquired | -22.9% (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M | 2,819 | · | · | 25,349 Direct | -10.01% | Disposed | (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M | 7,878 | · | · | 23,624 Direct | -25.01% | Disposed | (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M | 5,502 | · | · | 5,500 Direct | -50.01% | Disposed | (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M | 5,836 | · | · | 2,500 Direct | -70.01% | Disposed | (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M | 5,836 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | S 10b5-1 | 3,200 | $60.22 | $192,704 | 24,887 Direct | -11.39% | Disposed | -58.6% (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | S 10b5-1 | 24,671 | $59.77 | $1,474,586 | 28,087 Direct | -46.76% | Disposed | -58.3% (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M 10b5-1 | 2,819 | $43.54 | $122,739 | 52,758 Direct | +5.64% | Acquired | -42.7% (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M 10b5-1 | 7,878 | $38.35 | $302,121 | 49,939 Direct | +18.73% | Acquired | -35.0% (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M 10b5-1 | 5,502 | $44.20 | $243,188 | 42,061 Direct | +15.05% | Acquired | -43.6% (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M 10b5-1 | 5,836 | $32.35 | $188,795 | 36,559 Direct | +19.00% | Acquired | -22.9% (price as of 2026-10-06) |
| Sept. 17, 2020 | PCRX | M 10b5-1 | 5,836 | $40.34 | $235,424 | 30,723 Direct | +23.45% | Acquired | -38.2% (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M | 2,816 | · | · | 28,168 Direct | -9.09% | Disposed | (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M | 7,874 | · | · | 31,502 Direct | -20.00% | Disposed | (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M | 5,499 | · | · | 11,002 Direct | -33.33% | Disposed | (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M | 5,832 | · | · | 8,336 Direct | -41.16% | Disposed | (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M | 5,832 | · | · | 5,836 Direct | -49.98% | Disposed | (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | S 10b5-1 | 21,244 | $60.33 | $1,281,651 | 24,887 Direct | -46.05% | Disposed | -58.7% (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | S 10b5-1 | 6,609 | $59.54 | $393,500 | 46,131 Direct | -12.53% | Disposed | -58.1% (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M 10b5-1 | 2,816 | $43.54 | $122,609 | 52,740 Direct | +5.64% | Acquired | -42.7% (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M 10b5-1 | 7,874 | $38.35 | $301,968 | 49,924 Direct | +18.73% | Acquired | -35.0% (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M 10b5-1 | 5,499 | $44.20 | $243,056 | 42,050 Direct | +15.04% | Acquired | -43.6% (price as of 2026-10-06) |
| Sept. 16, 2020 | PCRX | M 10b5-1 | 5,832 | $32.35 | $188,665 | 36,551 Direct | +18.98% | Acquired | -22.9% (price as of 2026-10-06) |
| Sept. 15, 2020 | PCRX | M | 2,816 | · | · | 30,984 Direct | -8.33% | Disposed | (price as of 2026-10-06) |
| Sept. 15, 2020 | PCRX | M | 7,874 | · | · | 39,376 Direct | -16.66% | Disposed | (price as of 2026-10-06) |
| Sept. 15, 2020 | PCRX | M | 5,499 | · | · | 16,501 Direct | -25.00% | Disposed | (price as of 2026-10-06) |
| Sept. 15, 2020 | PCRX | M | 5,832 | · | · | 14,168 Direct | -29.16% | Disposed | (price as of 2026-10-06) |
| Sept. 15, 2020 | PCRX | M | 5,832 | · | · | 11,668 Direct | -33.33% | Disposed | (price as of 2026-10-06) |
Showing latest 100 of 143 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 14, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.74 | June 14, 2033 | 27,500 | Acquired |
| June 8, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $59.39 | June 8, 2032 | 24,800 | Acquired |
| March 21, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $47.65 | June 9, 2030 | 2,188 | Disposed |
| March 21, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $43.54 | June 5, 2029 | 2,112 | Disposed |
| March 21, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 2,953 | Disposed |
| Feb. 25, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 2,050 | Disposed |
| Feb. 16, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 10 | Disposed |
| Feb. 10, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 800 | Disposed |
| Feb. 4, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 1,000 | Disposed |
| Jan. 21, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 200 | Disposed |
| Jan. 19, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 2,199 | Disposed |
| Jan. 18, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $47.65 | June 9, 2030 | 13,127 | Disposed |
| Jan. 18, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $43.54 | June 5, 2029 | 6,338 | Disposed |
| Jan. 18, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 2,600 | Disposed |
| Jan. 18, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.20 | June 14, 2027 | 1,375 | Disposed |
| June 9, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock | $60.96 | June 9, 2031 | 17,500 | Acquired |
| April 13, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock | $43.54 | June 5, 2029 | 6,339 | Disposed |
| April 13, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 8,859 | Disposed |
| April 13, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.20 | June 14, 2027 | 4,125 | Disposed |
| April 13, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock | $32.35 | Dec. 7, 2026 | 2,500 | Disposed |
| Sept. 17, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $43.54 | June 5, 2029 | 2,819 | Disposed |
| Sept. 17, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 7,878 | Disposed |
| Sept. 17, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.20 | June 14, 2027 | 5,502 | Disposed |
| Sept. 17, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $32.35 | Dec. 7, 2026 | 5,836 | Disposed |
| Sept. 17, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $40.34 | June 15, 2026 | 5,836 | Disposed |
| Sept. 16, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $43.54 | June 5, 2029 | 2,816 | Disposed |
| Sept. 16, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 7,874 | Disposed |
| Sept. 16, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.20 | June 14, 2027 | 5,499 | Disposed |
| Sept. 16, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $32.35 | Dec. 7, 2026 | 5,832 | Disposed |
| Sept. 16, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $40.34 | June 15, 2026 | 5,832 | Disposed |
| Sept. 15, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $43.54 | June 5, 2029 | 2,816 | Disposed |
| Sept. 15, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 7,874 | Disposed |
| Sept. 15, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.20 | June 14, 2027 | 5,499 | Disposed |
| Sept. 15, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $32.35 | Dec. 7, 2026 | 5,832 | Disposed |
| Sept. 15, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $40.34 | June 15, 2026 | 5,832 | Disposed |
| June 9, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $47.65 | June 9, 2030 | 35,000 | Acquired |
| June 5, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock | $43.54 | June 5, 2029 | 33,800 | Acquired |
| June 13, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 47,250 | Acquired |
| Nov. 17, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $25.37 | March 5, 2023 | 7,857 | Disposed |
| Nov. 16, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $25.37 | March 5, 2023 | 2,143 | Disposed |
| June 14, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.20 | June 14, 2027 | 22,000 | Acquired |
| May 15, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $10.81 | June 5, 2022 | 11,979 | Disposed |
| May 15, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $10.52 | March 2, 2022 | 5,937 | Disposed |
| May 15, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $9.25 | Oct. 19, 2021 | 3,125 | Disposed |
| Dec. 7, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock | $32.35 | Dec. 7, 2026 | 20,000 | Acquired |
| June 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock | $40.34 | June 15, 2026 | 17,500 | Acquired |
| June 3, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock | $79.43 | June 3, 2025 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 14, 2014 | PCRX | Stock Option (Right to Buy) | 3,125 | Direct |
| Oct. 14, 2014 | PCRX | Stock Option (Right to Buy) | 5,937 | Direct |
| Oct. 14, 2014 | PCRX | Stock Option (Right to Buy) | 11,979 | Direct |
| Oct. 14, 2014 | PCRX | Stock Option (Right to Buy) | 10,000 | Direct |
| Oct. 14, 2014 | PCRX | Stock Option (Right to Buy) | 40,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $501,018 | $225,900 | $424,203 | $438,138 | · | · | $11,602 | $1,600,861 |
| 2022 | $457,046 | $330,400 | $587,961 | $621,240 | · | · | $12,188 | $2,008,835 |
| 2019 | $479,231 | $225,000 | $243,824 | $720,919 | · | · | $23,743 | $1,692,717 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.